SCHEMBL222490

SCHEMBL222490

C1=CNC=CN=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8465762 0.97 — —
Hydrochloric Acid SCHEMBL6632772 0.97 — —
SCHEMBL27789289 0.97 — —
Hydrochloric Acid SCHEMBL5197777 0.97 — —
Benzene SCHEMBL29136255 0.94 — —
Hydrazine SCHEMBL8839038 0.94 — —
Hydrochloric Acid SCHEMBL29406158 0.94 — —
SCHEMBL25329671 0.85 — —
SCHEMBL31675861 0.84 — —
SCHEMBL29993421 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1622 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025224085-A1 COMPOUNDS CAPABLE OF ACTING ON S1R AS WELL AS ON SEH AND USES THEREOF UNIVERSITAT DE BARCELONA (ES) 2025-10-30 — — WO claimed
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 — — WO claimed
US-12252492-B2 Substituted fused pyrrolo-diazepinones and uses thereof NORTHWESTERN UNIVERSITY (US) 2025-03-18 — — US claimed
CN-115650936-B Preparation method of (tert-butyl (3) -1, 4-diazapine-1-propyl) carbamate 天津药明康德新药开发有限公司 2024-11-01 — — CN claimed
WO-2023142618-A1 SYNTHESIS METHOD FOR EUPHORBIA DITERPENOID PEPLUANOL A 浙江大学杭州国际科创中心 2023-08-03 — — WO claimed
CN-115942938-A Medicine for preventing or treating irritable bowel syndrome or inflammatory bowel disease 比萨大学 2023-04-07 — — CN claimed
WO-2023036995-A1 ALKYNYLCARBINOLS WITH HIGH CYTOTOXICITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-03-16 — — WO claimed
WO-2023030453-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF 四川海思科制药有限公司 2023-03-09 — — WO claimed
EP-4126229-A1 MTORC1 MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2023-02-08 — — EP claimed
CN-115650936-A Preparation method of (tert-butyl (3) -1,4-diazepine-1-propyl) carbamate 天津药明康德新药开发有限公司 2023-01-31 — — CN claimed
EP-1369420-A1 Inhibitors of the GPib - vWF interaction Aventis Pharma Deutschland GmbH (DE) 2003-12-10 — — EP claimed
US-20030199689-A1 New indole derivatives as factor Xa inhibitors SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2003-10-23 — — US claimed
US-20030176439-A1 Urea derivatives with antiproteolytic activity AVENTIS PHARMA DUTSCHLAND GMBH 2003-09-18 — — US claimed
US-6599903-B2 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof. SOCIETE DE CONSEILS DE RECHERCHES D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2003-07-29 — — US claimed
WO-2003044014-A1 INDOLE-2-CARBOXAMIDES AS FACTOR XA INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-05-30 — — WO claimed
EP-1314733-A1 Indole-2-carboxamides as factor Xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2003-05-28 — — EP claimed
US-20020198195-A1 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2002-12-26 — — US claimed
WO-1996029316-A1 NEW SULFONE ESTER ANALOGUES OF iso-CLOZAPINE AND RELATED STRUCTURES: ATYPICAL NEUROLEPTICS WIKSTROEM HAAKAN (NL) 1996-09-26 — — WO claimed
EP-0240899-B1 1,4-DIAZEPINE BOEHRINGER INGELHEIM KG (DE) 1992-08-19 — — EP claimed
EP-0446133-A1 4H-Pyrrolo[1,2-a]thieno[3,2-f][1,4]diazepine derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1991-09-11 — — EP claimed
Send feedback